Chemoinformaics analysis of 4-CAFFEOYLQUINIC-ACID
Molecular Weight | 209.632 | nRot | 2 |
Heavy Atom Molecular Weight | 201.568 | nRig | 11 |
Exact Molecular Weight | 209.024 | nRing | 2 |
Solubility: LogS | -2.721 | nHRing | 1 |
Solubility: LogP | 2.516 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
nHA | 1 | APOL | 26.9183 |
nHD | 2 | BPOL | 9.97366 |
QED | 0.798 |
Synth | 2.124 |
Natural Product Likeliness | -0.386 |
NR-PPAR-gamma | 0.97 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.575 |
MDCK | 0.0000268 |
BBB | 0.214 |
PPB | 0.942215 |
VDSS | 0.265 |
FU | 0.0412243 |
CYP1A2-inh | 0.341 |
CYP1A2-sub | 0.298 |
CYP2c19-inh | 0.121 |
CYP2c19-sub | 0.082 |
CYP2c9-inh | 0.164 |
CYP2c9-sub | 0.972 |
CYP2d6-inh | 0.101 |
CYP2d6-sub | 0.435 |
CYP3a4-inh | 0.048 |
CYP3a4-sub | 0.142 |
CL | 5.001 |
T12 | 0.919 |
hERG | 0.02 |
Ames | 0.094 |
ROA | 0.455 |
SkinSen | 0.683 |
Carcinogencity | 0.194 |
EI | 0.762 |
Respiratory | 0.401 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.733591 |